Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.990
0.00 (0.00%)
At close: Apr 28, 2026
113.94%
Market Cap 101.77M
Revenue (ttm) 34.70M
Net Income (ttm) 7.22M
Shares Out 36.00M
EPS (ttm) 0.20
PE Ratio 14.11
Forward PE n/a
Dividend 0.05 (1.88%)
Ex-Dividend Date Apr 16, 2026
Volume 1,500
Average Volume 5,420
Open n/a
Previous Close 3.990
Day's Range 3.980 - 3.990
52-Week Range 1.775 - 3.990
Beta -0.04
RSI 94.28
Earnings Date Apr 15, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $48.95 million, an increase of 22.91% compared to the previous year's $39.82 million. Earnings were $10.18 million, an increase of 102.13%.

Financial numbers in USD Financial Statements

News

There is no news available yet.